| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02090053 |
| P698 | PubMed publication ID | 8281873 |
| P2093 | author name string | M Plebani | |
| A Floreani | |||
| M Chiaramonte | |||
| R Naccarato | |||
| M Mazzetto | |||
| F Zappalà | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Pharmacological aspects and therapeutic effects of ursodeoxycholic acid | Q38141353 | ||
| Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis | Q43729599 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus | Q49138901 | ||
| Quantitative analysis of bile acids in serum and bile, using gas--liquid chromatography. | Q51675488 | ||
| Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. | Q53441958 | ||
| Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis | Q68082565 | ||
| Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage | Q68257554 | ||
| Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study | Q68781360 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Effect of different doses of ursodeoxycholic acid in chronic liver disease | Q69405806 | ||
| The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis | Q69550249 | ||
| Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis? | Q69787622 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis | Q69917807 | ||
| Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid | Q69917995 | ||
| Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis | Q69990802 | ||
| The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease | Q70618924 | ||
| Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease | Q70618927 | ||
| Primary biliary cirrhosis | Q72331434 | ||
| P433 | issue | 1 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 9-14 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. | |
| P478 | volume | 39 |
| Q40955916 | Detection of hepatic fibrogenesis: a review of available techniques |
| Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
| Q53570884 | From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament. |
| Q44018756 | Gastric neuroendocrine tumors in a 2-year oncogenicity study with CD-1 mice |
| Q40499906 | Hepatic disorders. Features and appropriate management |
| Q73715566 | Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver |
| Q58803462 | Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis |
| Q44004769 | Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis |
| Q35272532 | Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. |
| Q40974682 | The ursodeoxycholic acid story in primary biliary cirrhosis |
| Q77619532 | Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study |
| Q42699503 | Ursodeoxycholic acid and primary biliary cirrhosis |
| Q72210615 | Ursodeoxycholic acid therapy in primary biliary cirrhosis |
Search more.